Nnompe ho OEM ODM Adetɔ Krataa Fitaa a Wɔde Ma Latin Amerika Wɔn a Wɔkyekyɛ

     

Latin Amerika nnompe ho nnuru a wɔkyekyɛ no yɛ adwuma wɔ medtech mmeae a wɔahyɛ ho mmara sen biara, a wɔde nneɛma kɔ baabiara kɛse no biako mu. Wo aguadi mu nkonimdi gyina levers abien a wubetumi ayɛ ankasa so: OEM/ODM hokafo a wopaw ne ɔkwan a wofa so yɛ apam ma quality, delivery, ne co‐development. Saa krataa fitaa yi ma wo adetɔ ho agodie nwoma a wode bɛsɔ wɔn a wɔde nneɛma ma no ahwɛ, de‐risk registrations, na woakyekye tumi a wode bɛyɛ nneɛma a ɛsono emu biara a woremma wo brand no nkɔto compliance surprises.

Apam no ni: mfaso a emu yɛ den sen biara a ɛwɔ hɔ ma wɔn a wɔkyekyɛ nneɛma wɔ Brazil, Argentina, Chile, Colombia, ne Peru no nyɛ bo kɛkɛ. Ɛyɛ ayɔnkofa ne nnompe OEM ODM yɛfo a obetumi ne wo ayɛ biako —a ɛma akwan horow no yɛ nokware, ɛyɛ nhwɛso ntɛmntɛm, na ɛboa sɔhwɛ a ɛto so abiɛsa —bere a ɛda so ara bɔ bere a wɔde ma wɔ bere ano na ɛde SLA ahorow a ɛda adi pefee a wubetumi ahyɛ no ma.

Saa krataa yi yɛ adanseɛ a ɛdi anim na ɛyɛ nea asiane biara nni ho sɛ wɔdi mmara so. Ɛbata nneɛma titiriw anaa nea wogye tom kɛse ho ma mmara kwan so akwanhwɛ ne nneyɛe pa, na ɛkyerɛ saa nneɛma no ase kɔ nneɛma a wobɛtɔ ho nnwinnade a wubetumi de adi dwuma ɔkyena.

Nneɛma atitiriw a wɔde kɔ

• Fa co‐development tumi di kan: hwehwɛ sɛ wɔyɛ nhyehyɛe a wɔakyerɛw so sɛ wɔbɛgye atom (IQ/OQ/PQ), nsakraeɛ sohwɛ SOPs, ne nneɛma/mfiri sɔhwɛ adanseɛ a ɛne ASTM/ISO ne gua so akwan hyia.

• Fa nea wubetumi asusuw ho apam: kyerɛkyerɛ OTD/OTIF, ahobammɔ stock, ne ntɛmpɛ logistics SLA ahorow mu sɛnea nneɛma abusua te; fa hokwan a wɔde di adanseɛ ne asotwe/agyedeɛ a ɛbata KPI a wɔtumi yɛ ho akontaabuo ho ka ho.

• Yɛ ahoboa a wɔde kyerɛw wɔn din wɔ bere koro mu: fa mfiridwuma ho nkrataa hyia EU MDR Annex II/III nhyehyɛe ne FDA akwanhwɛ a ɛnyɛ ayaresabea; fa aban portals hwɛ Brazil B‐GMP ne Colombia UDI bere nhyehyɛe ahorow no mu.

• Bisa OEM/ODM validation pack a edi mũ wɔ anim: nsakraeɛ control adwumayɛ kwan, process validation matrix, prototype review checklist, ne nneɛma/biocompatibility/sterylization adanse.

• Fa boɔ ne asiane‐kyɛ nhyehyɛeɛ no di dwuma: MOQ tiers, lead‐time bands, FX/tariff pass‐through logic, ne after‐sales SLA (mmuaeɛ, nsiesie, spares) de bɔ margins ho ban.

---

Nea enti a co‐development ne orthopedic OEM ODM hokafo a ɔfata sesa nea efi mu ba

Wɔn a wɔkyekyɛ nneɛma wɔ LATAM no hyia adetɔn kyinhyia tenten a oprehyɛn ho oduruyɛfo a wɔfa wɔn sɛ wɔn mma, bere a wɔde yɛ tender, ne wɔn din a wɔkyerɛw a ɛyɛ den na ɛkanyan. Ntaa ntaa nka nea w’aduruyɛfo a wɔyɛ oprehyɛn bisa ankasa wɔ akyi berɛmo, ahodwiriw, ne nkwaa mu ho asɛm. Nnompe ho OEM ODM yɔnko a ɔwɔ nkɔsoɔ a ɛho akokwaw nneyɛeɛ ma wotumi de nneɛma a ɛwɔ hɔ no si hɔ, san ka ho asɛm ntɛmntɛm, na wokyerɛw adanseɛ wɔ akwan a mmarahyɛfoɔ ne ayaresabea boayikuo ahodoɔ gye tom so.

Dɛn pɔtee na ɛma nkɔso bere a nkɔso a wɔbom yɛ no yɛ nokware na ɛnyɛ asɛmti kɛkɛ no?

• Faster design‐to‐first‐case denam prototyping a ɛyɛ ntɛmntɛm a wɔakyekyere no wɔ nhyehyɛe ahorow a wɔakyerɛkyerɛ mu a wɔde bɛkyerɛ sɛ ɛyɛ nokware so.

• Asiane a ɛwɔ mmara mu a ɛba fam bere a mfiridwuma ho nkrataa kyerɛ nhyehyɛe ahorow a wɔagye atom (sɛ nhwɛso no, EU MDR Annex II/III), ne bere a sɔhwɛ nhyehyɛe ahorow a ɛnyɛ ayaresabea no fata mfiri.

• Nsonsonoe a ɛyɛ mmerɛw a wotumi hu a wɔde variants ne nnwinnade a wɔayɛ ama mpɔtam hɔ nsɛnkyerɛnne —a wɔmfa traceability anaa revalidation nteɛso mmɔ afɔre.

Sɛ wosɔ wɔn a wɔde nneɛma ma baanu a wɔn bo yɛ pɛ hwɛ a, wobɛtaa apaw nea ɔwɔ validation asɛm a eye sen biara: IQ/OQ/PQ a edi mũ, nsakrae sohwɛ a ɛkanyan pefee, ne sɔhwɛ a ɛto so abiɛsa a wɔde tua ho ka. Ɛno ne ɔhokafoɔ a ɔbɛtumi atwa ayaresabea akontabuo mu na wama wo nsuo afiri no akɔ so.

---

LATAM mmara kwan so agodie nhoma no wɔ animtiaabu mu

Brazil — ANVISA RDC 751/2022 ne B‐GMP

• Class III nnompe a wɔde hyɛ nipadua mu no hia Registro ne mfiridwuma ho krataa a edi mũ; wɔhwɛ kwan sɛ wɔn a wɔyɛ nneɛma no benya Brazil GMP (B‐GMP) adansedi krataa. Nsɛm a wɔaka abom a agye din kyerɛkyerɛ nhyehyɛe dedaw a wɔde besi ananmu ne sɛnea wɔde bɛyɛ IMDRF‐style mfiridwuma ho nkrataa mu. Hwɛ Johner Asoɛe no nhwehwɛmu a wɔyɛe wɔ aduruyɛ mfiri a wɔpene so wɔ Brazil ne gua so nsɛm a ɛfoa so te sɛ Rimsys Brazil ɔman kratafa a ɛfa nsɛm a ɛfa ho ne nhyehyɛe ho nkyerɛkyerɛmu ho.

• UDI: Nneɛma a ɛto so abien pii twe adwene si UDI labeling bere a wɔde yɛ no nkakrankakra ma akuw a asiane kɛse wom; hwɛ sɛ mprempren nhyehyɛe no yɛ nokware tẽẽ wɔ ANVISA mmara kwan so ansa na woawie nkyerɛwde ne IFU ahorow.

Colombia — INVIMA UDI ne nkyerɛase gyinapɛn

• Resolution 1405/2022 de UDI‐DI coding ne semantic amanneɛbɔ a wɔde fa INVIMA platform so de maeɛ baeɛ. Consulting updates hyɛ no nsow sɛ platform no go‐live wɔ Feb 8, 2024 na phased deadlines kɔ 2025/2026 denam device class. Cross‐check wo device class ne deadlines wɔ INVIMA aban nkitahodi so. Nsɛm a ɛfa ho a mfasoɔ wɔ so: Veraque Consulting nkyerɛkyerɛmufoɔ wɔ semantic standard ne UDI platform ne wiase nyinaa mmara foforɔ a ɛfiri Emergo a ɛbɔ dwumadie no mua.

EU MDR ne FDA nhyehyɛe ahorow sɛ nkrataa a wɔde hyɛ mu

• EU MDR Annex II/III a wode bedi dwuma sɛ akyi dompe ama wo mfiridwuma ho nkrataa no boa ma adanse a ɛwɔ gua ahorow so no hyia. Nsɛm a wɔaboaboa ano no ne wobetumi anya wɔ EUR‐Lex , a ɛkyerɛ mfiri ho nkyerɛkyerɛmu a wɔhwɛ kwan, GSPR asase mfonini, ne nsɛm a wɔde di adanse/gye di, ne PMS/PMCF nneɛma a wɔde yɛ nneɛma a wɔde hyɛ nipadua mu.

• Wɔ U.S. akwan a ɛwɔ akwanhwɛ ahorow a ɛnyɛ ayaresabea so nkɛntɛnso wɔ wiase nyinaa fam no,... FDA akwankyerɛ a wɔayɛ a ɛfa adanse a wɔhwɛ kwan ma 510(k) implant devices ne agency’s ISO 10993‐1 biocompatibility akwankyerɛ ma sɔhwɛ a egyina asiane so, sterilization validation (SAL 10−6), ne shelf‐life akwan a ɛsɛ sɛ adetɔ akuw hwehwɛ wɔ OEM fael ahorow mu no mu da hɔ.

Argentina (ANMAT) ne Peru (DIGEMID) — di nsɛm pɔtee bi ho adanse wɔ aban portals so

• Guadi abien no nyinaa hwehwɛ sɛ wɔwɔ mpɔtam hɔfo ne mfiridwuma ho nkrataa a edi mũ, a mpɛn pii no wɔde Spainfo nkyerɛwde ne IFU ahorow ahyɛ mu. Esiane sɛ dispositions ne portals dane nti, kyekye verification step wɔ wo RACI mu na si ahwehwɛdeɛ a ɛtwa toɔ no so dua wɔ ANMAT official site ne DIGEMID portal ansa na dossier freeze na wɔatintim.

---

Supply ne delivery framework a wobɛtumi ayɛ apam wɔ so

Worentumi nni nea wonkyerɛkyerɛ mu no ho dwuma. Wɔ apam ne S&OP nhyiamu mu no, akuo ahodoɔ taa de OTD, OTIF, ne 'lead time' di dwuma wɔ ɔkwan a ɛnyɛ den so. Fa kasa ne susudua nsɛntitiriw no hyɛ gyinapɛn mu na ama obiara adi nokware na ama wɔatumi adi credits/penalties so.

Nkyerɛase ahorow ne ɔkwan a wɔfa so yɛ adwuma

• OTD (On‐Time Delivery): nneɛma a wɔde kɔma wɔ da a wɔahyɛ ho bɔ no anaa ansa na ɛreba, a wɔsusuu wɔ Incoterm nsa a wɔapene so (sɛ nhwɛso no, FCA/FOB/CIF). Paw bere biako ma susuw —ex‐works date vs. proof‐of‐delivery —na kyerɛw wɔ MSA no mu.

• OTIF (On‐Time, In‐Full): nneɛma a wɔde kɔ baabi a ɛfata, wɔ bere ano, a line items ne dodow nyinaa adi ho dwuma. Ɔfã bi a wɔhyɛ no ma no nyɛ 'wɔ ne nyinaa mu.'

• Fill rate: ɔha biara mu nkyem a ɛyɛ order lines anaa units a wɔde mena vs. a wɔsrɛe wɔ mfɛnsere a wɔahyɛ ho bɔ no mu. Fa line‐item fill rate di dwuma ma implants de kyere nketewa nanso ɛho hia a ɛyera.

Target bands (a adanse a wɔde ama, a wɔbɛgye atom wɔ wo RFP mu) .

• Nneɛma a wɔde hyɛ nipadua mu a ɛho hia (Klas III, oprehyɛn‐a wɔayɛ ho nhyehyɛe): OTD ≥95%; OTIF ≥93–95% na ɛwɔ hɔ; line‐item fill rate ≥98% ma SKU ahorow a wɔakora so. Ntɛmntɛm mmuae mfɛnsere <24–48 nnɔnhwerew baabi a ɛbɛyɛ yiye.

• Nneɛma/nnwinnade a ɛnyɛ nea ɛho hia: OTD ≥92%; OTIF ≥90–92% na ɛwɔ hɔ.

KPI pon a mfaso wɔ so a wode bɛka wo MSA

Aguade abusua no ho	Bere a wɔde di dwuma daa (kalenda nna)	Stocking nhyehyɛe	Botae OTD	Botae OTIF	Line‐item fill
Nneɛma a wɔde hyɛ akyi berɛmo mu (nneɛma akɛse a wɔde asie) .	14–30 na ɛwɔ hɔ	Ɔmantam ahobammɔ ho nneɛma a wɔde asie; consignment ma SKU ahorow 30 a ɛwɔ soro	≥95% na ɛwɔ hɔ.	≥95% na ɛwɔ hɔ.	≥98% na ɛwɔ hɔ.
Amanne akyi berɛmo/ahodwiriwde ahorow	30–60 na ɛwɔ hɔ	Build‐to‐order a wobɛhyehyɛ	≥92% na ɛwɔ hɔ.	≥92% na ɛwɔ hɔ.	≥95% na ɛwɔ hɔ.
Trauma mprɛte/nkuruwankuruwa (gyinabea) .	21–45 na ɛwɔ hɔ	Central ahobammɔ stock + anim stocking	≥94% na ɛwɔ hɔ.	≥93% na ɛwɔ hɔ.	≥97% na ɛwɔ hɔ.
Nnwinnade ahorow (refurb/complete) .	30–60 na ɛwɔ hɔ	Rotational pool a ɛwɔ nsiesie SLA	≥92% na ɛwɔ hɔ.	≥90% na ɛwɔ hɔ.	≥95% na ɛwɔ hɔ.

Nsusuiɛ ho nsɛm: Kyerɛw sɛ ebia wɔbu OTD wɔ berɛ a wɔde rekɔ (FCA/FOB) anaa wɔde rekɔ (CIF/DAP) ne sɛdeɛ wɔdi tumi a ɛboro soɔ a wɔayi afiri mu ho dwuma. Sɛ wofa benchmarks ka wɔ wo mu a, fa ma ɛne KPI akwan a wɔagye tom no hyia sɛnea ɛbɛyɛ a wo dashboard ahorow no ne nea wɔn a wɔde nneɛma ma no hu wɔ wɔn QBR ahorow mu no bɛyɛ pɛ. Sɛ wopɛ ɔkwan a wɔfa so yɛ adwuma ho nsɛm a ɛfa OTD nkyerɛaseɛ ne adetɔnfoɔ KPI nhyehyɛɛ ho a, hwɛ nsusuiɛ a mfasoɔ wɔ so a ɛfa bere a wɔde ma metrics a ɛkyerɛkyerɛ akontabuo afiri ne nhyiamu a ɛwɔ akuo ahodoɔ mu.

Logistics SLA ne nhyehyɛe a wɔyɛ wɔ nneɛma a esisi ho

• Booking ne nkrataa SLA: si so dua sɛ wɔatwa mu (sɛ nhwɛso no, nkrataa a wɔde amena ≥3 adwuma nna ansa na wɔde rekɔ), aguadi ho nkrataa a wɔde tua ho ka no mu pɛpɛɛpɛyɛ nhwehwɛmu, ne towtua ho mmara a ɛne ne ho hyia.

• Brokerage ne clearance: paw brokers; kyerɛkyerɛ escalation nnua ne proof‐of‐clearance bere nhyehyɛe mu; hwɛ ɔman pɔtee bi agodie nhoma ahorow so.

• Ntɛmntɛm ho nhyehyɛe: kyerɛw nneɛma a ɛkanyan (sɛ nhwɛso no, oprehyɛn‐critical backorder), akwantu akwan a ɛwɔ hɔ, ne gyinaesi tumidi. Target mmuae wɔ <24–48 nnɔnhwerew mu ma nsɛm a emu yɛ den.

• Traceability ne UDI: hwɛ sɛ label/UDI ayɛ krado na woakwati amanne anaa ayaresabea a wɔbɛpow.

Dɛn nti na wɔyɛ katee? Efisɛ tender scorings ne oprehyɛnfo ahotoso hu amane bere a backordered size biako twa OR da bi mu no. Ɛdenam OTD/OTIF a wobɛyɛ no apam so no, wunya levers a wode besiesie ɔkwan a worenfa so mfa wo ho nhyɛ abusuabɔ nkutoo mu nsiesie so.

---

OEM/ODM mfiridwuma mu validation pack no: nea papa te

Eyi ne koma a ɛwɔ nnompe mu OEM ODM nhwehwɛmu mu. Bisa wɔn a wɔpɛ sɛ wɔyɛ ahokafo no ma wɔmma wɔn pack a edi mũ a wobetumi asan ahwɛ mu. Botae no nyɛ nkrataa a wɔde yɛ adwuma esiane n’ankasa yiyedi nti —ɛyɛ sɛ ɛbɛkyerɛ sɛ mfiri ne nhyehyɛe ho adanse no betumi agyina akontaabu, dinkyerɛw, ne ayaresabea nhwehwɛmu ano.

1. Sesa control SOP ne gyinaesi dua

• Triggers: nneɛma grade nsakrae, supplier nsakrae ma ade titiriw bi, machining nhyehyɛe nsakrae, surface ayaresa nsakrae, sterilization cycle update, labeling / UDI nsakrae, anaasɛ packaging supplier swap.

• Nsunsuansoɔ nhwehwɛmu: wɔayɛ ho mfonini akɔ asiane ho dwumadie (ISO 14971), GSPRs (sɛ wɔde MDR nhyehyɛeɛ di dwuma a), ne gua so nkrataa. Hwehwɛ sɛ RA/QA de ne nsa hyɛ aseɛ ne gyinaesie a ɛda adi pefee sɛ wɔbɛsan agye atom (biara nni hɔ/ɔfã/ɛyɛ ma) a nteaseɛ wom.

• Afuo mu nkitahodi: sɛ biribiara a ɛbɛtumi anya nkɛntɛnsoɔ wɔ ahobanbɔ/adwumayɛ so wɔ afuo mu a, hwɛ sɛ PMS/PMCF de nsɛm bɛba na wɔbɛma akɔ soro akɔ anidasoɔ nhyehyɛeɛ so.

2. Dwumadie a wɔde di dwuma no ho adansedie nhyehyɛeɛ (IQ/OQ/PQ) .

• IQ: nnwinnade, nnwinnade, softwea nkyerɛase ahorow, ne nneɛma a atwa yɛn ho ahyia ho ahwehwɛde ahorow a wɔakyerɛw atia nea wɔakyerɛ, a wɔatoto gyinapɛn ahorow a wɔde gye tom ne nea ɛtwetwe adwene mu.

• OQ: parameter nsɛnnennen wɔ normal/worst‐case ranges nyinaa mu, kyerɛ nhyehyɛe parameters a ɛho hia na wɔde control anohyeto ahorow si hɔ; adanse a ɛkyerɛ sɛ GR&R wɔ baabi a wɔde susudua nhyehyɛe ahorow di dwuma.

• PQ: mmirikatuo ahodoɔ a wɔyɛ daa a ɛkyerɛ tumi (CpK baabi a ɛfata) a ɛwɔ nhwɛsoɔ nhyehyɛeɛ a wɔadi kan akyerɛkyerɛ mu; sɛ wɔde sterilization, validation a ɛkyerɛ SAL 10−6 ne packaging validation sɛnea ISO 11607 kyerɛ.

• Nwoma map: validation master plan a ɛbata ankorankoro protocols/amanneɛbɔ ho, a ɛwɔ traceability to DHF ne nsakraeɛ kyerɛwtohɔ. Sɛ wopɛ nhyehyɛe a eye sen biara ne emu nsɛm a ɛne EU MDR tech doc akwanhwɛ hyia a, hwɛ Team‐NB no mfiridwuma ho nkrataa gyinabea krataa.

3. Nneɛma ne sɔhwɛ dossier

• Nneɛma a wɔde yɛ: Nhwehwɛmu adansedie nkrataa a ɛhwehwɛ ɔhyew/dodow mu kɔsi grades a wɔagye atom (sɛ nhwɛsoɔ no, ASTM F136 Ti‐6Al‐4V ELI, ASTM F138/139 316L, ASTM F1537 CoCr). Hwɛ supplier certs ne acceptance criteria so.

• Mfiridwuma mu sɔhwɛ: gyinapɛn a ɛfata mfiri (sɛ nhwɛso no, ASTM F1717 ma akyi berɛmo mu nneɛma a wɔayɛ, ASTM F2077 ma IBF mfiri, ASTM F382 ma mprɛte, ASTM F543 ma nkɔnsɔnkɔnsɔn), nsɛm a enye koraa a wɔpaw ho nkrataa, ne ntotoho a wɔde toto mfiri a wɔde gyina hɔ ma wɔ baabi a ɛfata. FDA adwumayɛ ho gyinapɛn nhoma a wɔde tintim mprɛte a ɛpaapae no yɛ nhwɛso a mfaso wɔ so a ɛkyerɛ sɛnea gyinapɛn ahorow de nsɛm a wɔde kɔma no hyɛ ase.

• Biocompatibility: nhyehyeɛ a ɛne ISO 10993‐1 exposure category hyia; nnuru su a wɔde awuduru ho asiane nhwehwɛmu wɔ baabi a wɔakyerɛ; test lab accreditation adanse.

• Sterilization ne packaging: ɔkwan pɔtee bi so validation ne residuals (sɛ EtO); packaging validation per ISO 11607 a ɛwɔ nkyekyɛmu simulation ne seal integrity.

• Reference index: emu index mapping a amanneɛbɔ foa GSPR anaa gua pɔtee bi akwanhwɛ so. Sɛ wopɛ gyinapɛn ahorow a ɛfa nipadua mu nneɛma a wɔde hyɛ nipadua mu ho a, hwɛ ASTM aduruyɛ mfiri ne implant gyinapɛn ahorow ho nsɛm a wɔaka abom.

4. Prototype nhwehwɛmu nhwehwɛmu nhyehyɛe

• DFM/DFA: manufacturability ne assembly nhwehwɛmu a wɔakyerɛw ne nneyɛe.

• Asiane ho nsɛm foforo: nkitahodi a ɛkɔ asiane mu nhwehwɛmu ne su titiriw ahorow so.

• Nhwehwɛmu nhyehyɛe: wɔakyerɛkyerɛ mu agye atom gyinapɛn ama prototype round (dimensional, mechanical, functional) ne anammɔn a edi hɔ a wɔayɛ ho nhyehyɛe.

• Release criteria: sɛnea prototype bɛyɛ design‐freeze candidate ne adanse foforo bɛn na ɛho hia.

Micro‐nhwɛso a mfaso wɔ so (a enni afã biara) .

• Bere a supplier qualification no, wo kuw no bisa IQ/OQ/PQ nhyehyɛe a edi mũ ma cervical plate foforo. OEM no de validation master plan, OQ parameter adesua ma machining ne passivation, na PQ de CpK tumi nsɛm tiawa tu mmirika. Wofa amanneɛbɔ ahorow fi wɔn mfiri ne nneɛma a wɔde kyekyere nneɛma ho adansedi mu na wosi so dua sɛ wɔayɛ ASTM F382 sɔhwɛ ho nhyehyɛe wɔ nea enye koraa no mu. Saa ade a wɔyɛ no pefee yi yɛ nea wɔtaa yɛ wɔ wɔn a wɔyɛ nneɛma a wɔn ho akokwaw mu; sɛ nhwɛso no, sɛ services overview wɔ XC Medico kyerɛ OEM/ODM adwumayɛ nhyehyɛe ne adwini tumi a wɔn a wɔkyekyɛ nneɛma betumi asusuw ho sɛ ɛne ne ho hyia.

---

Nnwinnade a wɔde tɔ nneɛma ne bo a wɔbɔ ho nhyehyɛe

Ɛsɛ sɛ wo RFP no ma ɛyɛ mmerɛw ma nnompe ho OEM ODM a wɔde nteɛso ma no sɛ wɔbɛyɛ ho biribi —na ɛyɛ den ma adetɔnfo a wonsiesiee wɔn ho sɛ wɔde nsonsonoe besie.

RFP ne adetɔnfo akontaabu ho nneɛma a ɛho hia

• QMS ne mmara: ISO 13485 adansedi krataa; emu akontaabu cadence; CAPA a etu mpɔn; nhyehyɛe a wɔde hwɛ nneɛma so; MDR‐style mfiridwuma ho nkrataa a wɔde kyerɛw nsɛm a ɛwɔ mu; adanse a ɛkyerɛ sɛ UDI‐ayɛ krado ama gua ahorow a wɔde wɔn ani asi so.

• Traceability ne ahotew: lot/heat traceability fi bar so kosi implant so; calibration nhyehyɛe; dan a ɛho tew mu nkyekyɛmu ne nneɛma a atwa yɛn ho ahyia a wɔhwɛ so wɔ baabi a ɛfata.

• Validation ne sɔhwɛ: validation master nhyehyɛe; IQ/OQ/PQ tebea sɛnea wɔyɛ no; mfiri/biocompatibility lab adansedi krataa a ɛto so abiɛsa.

• Nneɛma a wɔde kɔ ne ɔsom: gyinapɛn lead‐time bands sɛnea nneɛma abusua te; OTD/OTIF abakɔsɛm; ahobammɔ stock nhyehyɛe; ntɛmpɛ mu nneɛma a wɔde kɔ baabiara ho nhyehyɛe; after‐sales SLA (mmuae, nsiesie, spare parts a ɛwɔ hɔ).

Nneɛma bo a wɔbɔ ne asiane‐kyɛ ho akwan

• MOQ tiers: ɛne SKU a ɛho hia ne ABC nkyekyɛmu hyia; susuw MOQ ahorow a ɛkorɔn ho ma amanne ahorow a ahoɔhare sua nkutoo.

• Lead‐time bands: tintim na wɔsan hwɛ mu asram abiɛsa biara; tie penalties/credits to misses on bands ma mmusua a wɔde nneɛma ahyɛ mu.

• FX ne tariffs: kyerɛkyerɛ pass‐through thresholds mu na hwɛ cadence mu; susuw kɔla bands ho ma FX volatility.

• SLA a wɔtɔn akyi: mmuae bere ma mfiridwuma ho nsɛmmisa (sɛ nhwɛso no, ≤24h), bere a wɔde dannan nneɛma ma adwinnade siesie, ne afã horow a wɔde besi ananmu a ɛwɔ hɔ.

Sɛ wo RFP hyehyɛ saa nsɛmti yi pefee a, wɔn a wɔde nneɛma ma no ankasa paw. Wɔn a wɔbɛtumi aboa co‐development no de validation pack, KPI abakɔsɛm, ne stocking nhyehyɛeɛ a ɛyɛ nokware bɛma a wɔrentwentwɛn wɔn nan ase.

---

LATAM aguadi a ɛma wotumi yɛ adwuma: wɔn a wɔkyerɛw wɔn din, KOL ntetee, ne adanse a ɛkyerɛ sɛ ɛho ka sua

Nneɛma atitiriw a wɔde kyerɛw wɔn din ne ahoboa a wɔyɛ wɔ tender ho

• Si wo dinkyerɛw RACI ntɛm: hena na ɔkyerɛw IFU ne labeling, hena na ɔboaboa GSPR nhwehwɛmu kratasin no ano, hena na ɔwɔ nkyerɛase ahorow, ne nea ɔne mpɔtam hɔfo a wɔwɔ hɔ no di nkitaho. EU MDR Annex II/III nhyehyeɛ a wɔde yɛ ahwehwɛ no ma nneɛma a ɛwɔ mu a wɔbɛsan de adi dwuma wɔ gua ahodoɔ so no yɛ mmerɛ na ɛma akontabuo kɔ so yie. Sie anammɔn a wɔde di adanseɛ ma Brazil B‐GMP tebea ne Colombia UDI a wɔde bɛmena ansa na wɔatintim.

KOL ntetee ne mmofra a wɔfa wɔn sɛ wɔn mma

• Yɛ oprehyɛn nkyerɛkyerɛ ne wo OEM/ODM hokafo: cadaver labs, instrument dry‐runs, ne case selection akwankyerɛ a ɛne device IFUs hyia. Nteteeɛ ho kyerɛwtohɔ, wɔn a wɔbaa ase, ne nsɛm a wɔka boa boa ma wɔboa tender dossiers ne emu PMS.

Ka a wɔbɔ ho nhyehyɛe (ɛnyɛ nea ebefi mu aba ho nsɛm) .

• Wo ne ayaresabea so ahwɛfo nyɛ adwuma mfa nyɛ ɛka a wɔbɔ wɔ episode no nyinaa ho nhwɛso: implant set price, adwinnade a ɛwɔ hɔ, reprocessing costs, case bere tenten ho nsusuwii, ne backorder risk asotwe. Fa nhwɛsode no toto akwan horow a wubetumi apaw ho sen sɛ wobɛhyɛ bɔ sɛ wobɛkorɔn wɔ ayaresabea a wuntumi nkyerɛw.

---

Nkitahodi ho nsɛm a ɛbɔ wɔn a wɔkyekyɛ nneɛma ho ban

• Adanse a wobenya: akontabuo hokwan a ɛwɔ nkrataa a wɔde gye tom (wɔ NDA ase), a sɔhwɛ amanneɛbɔ ne nsakraeɛ sohwɛ ho kyerɛwtohɔ ka ho.

• Lead‐time commitments ne credits: credits a wɔde ma wɔ nneɛma a wɔde kɔ akyiri wɔ mmusua a wɔde nneɛma ahyɛ mu no ho; nsɛm a wɔayi afi mu pefee ama ahoɔden a ɛboro so a wɔakyerɛw ho asɛm.

• Ntɛmntɛm ho mmuaeɛ: wɔakyerɛkyerɛ nneɛma a ɛkanyan ne akwan a wɔfa so de nneɛma kɔ a ɛwɔ ɛka a wɔkyɛ ho mmara.

• Nsakrae ho amanneɛbɔ: amanneɛbɔ mfɛnsere a edi kan ma nsakrae biara a ɛhwehwɛ sɛ wɔsan gye tom anaasɛ wɔbɔ mmara ho amanneɛbɔ; hokwan a ɔwɔ sɛ ɔsrɛ sɛ wɔsan gye no fã bi/wie.

• Waranti ne afuom nneyɛeɛ: asɛdeɛ a ɛda adi pefee ma nhwehwɛmu mmoa, berɛ nhyehyɛeɛ a wɔde besi ananmu, ne asɛdeɛ a ɛfa nkaeɛ ho.

• IP ne tech transfer: ahobanbɔ ma co‐developed designs, tumi krataa nsɛm sɛ ɛsɛ sɛ adwinnan no sesa, ne escrow ma critical design files wɔ defined scenarios.

---

Anamɔn a edi hɔ ne nneɛma a wɔde bɛyɛ adwuma

Action checklist a wubetumi afi ase dapɛn yi

• Fa nnompe mu OEM ODM abatoɔfoɔ 3–5 din tiawa na fa RFP a ɛbisa sɛ: ISO 13485, validation master plan, nhwɛsoɔ IQ/OQ/PQ amanneɛbɔ, nneɛma/sɔhwɛ dossier index, OTD/OTIF abakɔsɛm, stocking nhyehyɛeɛ, ne ntɛmpɛ logistics SOP ma.

• Map wo botaeɛ dinkyerɛw na hwɛ mprempren ahwehwɛdeɛ wɔ ANVISA, INVIMA, ANMAT, ne DIGEMID portals so; fa wo tech doc no hyia EU MDR Annex II/III na boaboa FDA‐aligned nonclinical adanse ano.

• Draft wo supply ne pricing mechanism framework a KPI bands a emu da hɔ, FX/tariff mmara, ne after‐sales SLA; wo ne ɔman no mu sikasɛm ne adwumayɛ bɔ fekuw ansa na wɔayɛ nkitahodi.

Nneɛma a wɔapaw a ɛwɔ tumi a yɛaka ho asɛm wɔ atifi hɔ

• EU MDR nsɛm a wɔaboaboa ano a ɛfa EUR‐Lex ho ama Annex II/III nhyehyɛe ahorow.

• FDA adanse a wɔhwɛ kwan ma 510(k) mfiri a wɔde hyɛ nipadua mu ne FDA ISO 10993‐1 akwankyerɛ a ɛfa biocompatibility nhyehyɛe ho.

• Brazil mfiri a wɔpene so ho nsɛm tiawa (Johner Institute) ne Rimsys Brazil ho nsɛm a ɛfa nsɛm a ɛfa ho nhyehyɛe ho ntease; hwɛ UDI nna a ɛwɔ ANVISA portal no so.

• Colombia UDI/semantic gyinapɛn nsɛm a ɛfa ho via Veraque Afotuo ne a wiase nyinaa nsɛm foforo a efi Emergo ; si bere a wɔde bɛma no so dua wɔ INVIMA so.

• ASTM implant gyinapɛn ahorow ho nkyerɛkyerɛmu ma nneɛma ne mfiri sɔhwɛ scope.

• OTD kwan a wɔfa so kyerɛkyerɛ mu ma KPI a ɛne ne ho hyia wɔ akuo ahodoɔ mu.

• Team‐NB mfiridwuma ho nkrataa a wɔde yɛ adwuma yiye krataa ma MDR‐style fael nhyehyɛe.

---

Nkekaho: Nsɛmfua Nkyerɛase

• OTD (On‐Time Delivery): Nneɛma a wɔde bɛkɔ no ɔha biara mu nkyem 100 a wɔde kɔmaa da a wɔahyɛ ho bɔ wɔ Incoterms beae a wɔapene so no.

• OTIF (On‐Time, In‐Full): Nneɛma a wɔde mena wɔ bere ano no ɔha biara mu nkyem 100 a nneɛma ne dodow nyinaa ka ho sɛnea wɔkrae.

• IQ/OQ/PQ: Installation, Operational, ne Performance Qualification—nhyehyɛe a wɔde di dwuma nnidiso nnidiso a wɔde gye tom.

• GSPR: Ahobanbɔ ne Adwumayɛ ho Ahwehwɛdeɛ a ɛwɔ EU MDR Annex I ase.

• SAL 10−6: Sterility Assurance Level a wɔde asi wɔn ani so wɔ terminal sterilization validations mu.

• UDI: Unique Device Identification a wɔde di dwuma ma labeling ne traceability.

Hyɛ no nsow wɔ brand mention ho: Saa krataa fitaa yi de nhwɛsoɔ baako a ɛnyɛ afã biara, a ɛfa nsɛm a ɛfa ho a ɛkyerɛ OEM/ODM adwumayɛ nhyehyɛeɛ a ɛwɔ XC Medico site no so kaa ho sɛdeɛ ɛbɛyɛ a akenkanfoɔ bɛtumi ahunu sɛdeɛ wɔbɛsusu adwini ne validation nneyɛeɛ ho wɔ nneyɛeɛ mu. Sɛ wopɛ nsɛm a ɛfa ho a, san hwɛ XC Medico dwumadie ho nsɛm a wɔaka abom.